2GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
3Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
4Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
7Ng TP,Niti M,Tan WC,et al. Depressive symptoms and chronic ob- structive pulmonary disease:effect on mortalily, hospital readmission, symptom burden, functional status, and quality of life [ J ]. Arch Intern Med,2010,167 ( 1 ) :60 - 67.
8Vaguliene N,Zemaitis M,Lavinskiene S,et al. Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease[J]. BMC Immunol,2013,6(14) :36.
9Porszasz J ,Cao R,Morishige R,et al. Physiologic effects of an ambulatory ventilation system in chronic obstruc- tive pulmonary disease[J]. Am J Respir Crit Care Med, 2013,188(3) :334-342.
